Congressional Research Service Reports - 611 Matching Results

Search Results

Biotechnology: Commercialization of Academic Research
This report provides an overview of the commercialization of academic research h in the field of biotechnology. It offers a brief definition, background and policy analysis, as well as legislation and hearings regarding the topic.
Cancer Research: Selected Federal Spending and Morbidity and Mortality Statistics
This report shows federal spending at the National Institutes of Health (NIH) for research on selected cancer sites.
Disease Funding and NIH Priority Setting
Research at the National Institutes of Health (NIH) has strong political support, but a heated debate rages over the allocation of NIH funds among various diseases. NIH contends that decisions are made based on scientific opportunity while critics of the NIH process charge that spending often follows current politics and political correctness.
The NIH Recombinant DNA Guidelines: Brief History and Current Status
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
This report provides background on the research and potential applications of research that uses embryonic and adult stem cells. It also provides information about the current federal and state regulatory landscape, related Congressional and international actions, and relevant ethical concerns.
Stem Cell Research
This report provides background on the research and potential applications of research that uses embryonic and adult stem cells. It also provides information about the current federal and state regulatory landscape, related Congressional and international actions, and relevant ethical concerns.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
H.R. 6: The 21st Century Cures Act
Report about H.R. 6, the 21st Century Cures Act, which would reauthorize the National Institutes of Health (NIH) through FY2018 and provide other funding to the agency through FY2020.
The Genetic Information Nondiscrimination Act of 2008 (GINA)
This report provides background on genetic information, legal implications regarding the use of this information, and relevant laws. It also discusses the statutory provisions of the Genetic Information Nondiscrimination Act of 2008 (GINA).
Financing Catastrophic Risk: Summary of the Homeowners' Defense Act of 2009 (S. 505 and H.R. 2555)
This report discusses the drastic increase in demand for homeowners' insurance in Atlantic and Gulf Coast states following the devastation of Hurricane Katrina in 2005. This report also discusses various measures and efforts underway to enhance insurer capacity, pursue alternative forms of risk transfer, and create a national catastrophe financing facility, the last of which is an issue under considerable debate.
Counterterrorism Research and Development: Funding, Priority-setting, and Coordination
This report describes the basic R&D issues that concern the adequacy of planning/coordination mechanisms, including those in the Office of Science and Technology Policy and Office of Homeland Security; which counterterrorism R&D should be transferred to a new department; and how other R&D counterterrorism activities that are not transferred should be coordinated.
Counterterrorism Research and Development: Funding, Priority-setting, and Coordination
This report describes the basic R&D issues concern regarding the adequacy of planning/coordination mechanisms, including those in the Office of Science and Technology Policy and Office of Homeland Security; which counterterrorism R&D should be transferred to a new department; and how other R&D counterterrorism activities that are not transferred should be coordinated.
Federal Research and Development: Budgeting and Priority-Setting Issues, 107th Congress
No Description Available.
Federal Research and Development: Budgeting and Priority-Setting Issues, 107th Congress
No Description Available.
Federal Research and Development: Budgeting and Priority-Setting Issues, 107th Congress
No Description Available.
Federal Research and Development: Budgeting and Priority-Setting Issues, 107th Congress
No Description Available.
Federal Research and Development: Budgeting and Priority-Setting Issues, 107th Congress
No Description Available.
Federal Research and Development: Budgeting and Priority-Setting Issues, 107th Congress
No Description Available.
Federal Research and Development: Budgeting and Priority-Setting Issues, 107th Congress
No Description Available.
Federal Research and Development: Budgeting and Priority-Setting Issues, 107th Congress
Federal research and development (R&D) funding priorities reflect presidential policies and national needs. This report discusses past and projected R&D budgets and initiatives.
Federal Research and Development: Budgeting and Priority-Setting Issues, 108th Congress
This report discusses federal funding for research and development. National R&D funding continues to grow, but the federal R&D share has declined to less than 30% of the total. Debates focus on which fields of federal R&D should be increased and how to set priorities and to "balance" health and nonhealth fields.
Federal Research and Development: Budgeting and Priority-Setting Issues, 108th Congress
No Description Available.
Federal Research and Development: Budgeting and Priority-Setting Issues, 108th Congress
No Description Available.
Federal Research and Development: Budgeting and Priority-Setting Issues, 108th Congress
No Description Available.
Federal Research and Development: Budgeting and Priority-Setting Issues, 108th Congress
No Description Available.
Federal Research and Development: Budgeting and Priority-Setting Issues, 108th Congress
No Description Available.
Federal Research and Development: Budgeting and Priority-Setting Issues, 108th Congress
No Description Available.
Federal Research and Development: Budgeting and Priority-Setting Issues, 108th Congress
No Description Available.
Federal Research and Development: Budgeting and Priority-Setting Issues, 108th Congress
No Description Available.
Federal Research and Development: Budgeting and Priority-Setting Issues, 108th Congress
No Description Available.
Federal Research and Development: Budgeting and Priority-Setting Issues, 109th Congress
Federal research and development (R&D) funding priorities reflect presidential policies and national needs. For FY2007, R&D is requested at almost $137 billion of budget authority, about 1.8% more than enacted in FY2006. The FY2007 budget would fund three interagency R&D initiatives: networking and information technology; climate change science; and nanotechnology. The Administration is using performance measures for R&D budgeting, including the Government Performance and Results Act and the Program Assessment Rating Tool.
Federal Research and Development: Budgeting and Priority-Setting Issues, 109th Congress
This report summarizes current research and development (R&D) priority setting issues — in terms of expenditures; agency, topical, or field-specific priorities; and organizational arrangements to determine priorities.
Federal Research and Development Organization, Policy, and Funding for Counterterrorism
No Description Available.
Homeland Security and Combating Terrorism Research and Development: Funding, Organization, and Oversight
No Description Available.
Homeland Security and Counterterrorism Research and Development: Funding and Organization
No Description Available.
Homeland Security and Counterterrorism Research and Development: Funding, Organization, and Oversight
No Description Available.
Homeland Security and Counterterrorism Research and Development: Funding, Organization, and Oversight
No Description Available.